Skip to main content

Bharat Biotech's Covaxin gets DGCI approval for emergency use on children above 12 years

Vaccine for children: Covaxin has become the second Covid-19 vaccine to receive approval for emergency use on children in India. 



source https://www.jagranjosh.com/current-affairs/bharat-biotechs-covaxin-gets-approval-for-emergency-use-on-children-above-12-years-1640504743-1

Popular posts from this blog